Clinical trials
Phase 1 Squamous Cell Carcinoma of Head and Neck trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 5 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
| Active, not recruiting | 7 |
| Completed | 5 |
| Terminated | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sichuan Baili Pharmaceutical Co., Ltd. | 4 |
| West China Hospital | 4 |
| BeiGene | 2 |
| Eli Lilly and Company | 2 |
| HRYZ Biotech Co. | 2 |
| Novartis Pharmaceuticals | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| Allist Pharmaceuticals, Inc. | 1 |
| Bayer | 1 |
| Beijing Tongren Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 35 |
| Carcinoma, Non-Small-Cell Lung | 18 |
| Colorectal Neoplasms | 11 |
| Uterine Cervical Neoplasms | 7 |
| Triple Negative Breast Neoplasms | 6 |
| Esophageal Neoplasms | 5 |
| Esophageal Squamous Cell Carcinoma | 5 |
| Neoplasm Metastasis | 5 |
| Ovarian Neoplasms | 5 |
| Breast Neoplasms | 4 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.